论文部分内容阅读
目的观察乳腺浸润性导管癌以及导管内癌钙化灶在钼靶X线中的特点。方法对280例乳腺浸润性导管癌患者(乳腺浸润性导管癌组)和35例导管内癌患者(乳腺导管内癌组)在钼靶X线的图片资料进行回顾性分析,观察其临床特点。结果乳腺浸润性导管癌组中有145例(51.8%)患者的钼靶X线中可观察到钙化,其中出现钙化的患者有127例(45.4%)出现肿块,出现钙化但是没有出现肿块的有18例(6.4%);乳腺导管内癌组中有29例(82.9%)患者的钼靶X线中可观察到钙化,其中有6例(17.1%)出现钙化肿块,23例(65.7%)出现钙化但没有出现肿块。乳腺导管内癌组出现钙化及钙化无肿块的发生率高于乳腺浸润性导管癌组,但乳腺浸润性导管癌组中钙化伴肿块的发生率高于乳腺导管内癌组,差异均有统计学意义(P<0.05)。结论通过观察乳腺浸润性导管癌及乳腺导管内癌在钼靶X线中的特点分析,能够提高对乳腺浸润性导管癌及导管内癌的诊断,对提高各医院的医疗水平有一定的参考价值。
Objective To observe the characteristics of breast invasive ductal carcinoma and intraductal calcification in molybdenum target X-ray. Methods 280 patients with invasive ductal carcinoma of the breast (invasive ductal breast cancer group) and 35 cases of intraductal carcinoma (ductal intraductal carcinoma group) were retrospectively analyzed on mammographic X-ray images and the clinical features were observed. Results Of 145 (51.8%) breast invasive ductal carcinoma patients, calcification was observed in the mammographic X-ray. Of the patients who developed calcification, 127 (45.4%) showed calcification but no calcification 18 cases (6.4%). Calcification was observed in mammography X-ray in 29 cases (82.9%) of breast intraductal carcinomas, including 6 cases (17.1%) with calcified masses and 23 cases (65.7% Calcification but no lumps appeared. The incidence of calcification and calcification without lump in intraductal carcinoma group was higher than that in invasive ductal carcinoma group, but the incidence of calcification with lumps in invasive ductal carcinoma group was higher than that in intraductal carcinoma group, the difference was statistically significant Significance (P <0.05). Conclusion By observing the characteristics of breast invasive ductal carcinoma and intraductal carcinoma in mammography, it is possible to improve the diagnosis of invasive ductal carcinoma and intraductal carcinoma in breast and to improve the medical level in all hospitals .